These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1126 related items for PubMed ID: 18052749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP, Marley MS, Zhang Y, Eason AB, Nunley CL, Walz PH, Riddell KP, Galik PK, Brodersen BW, Givens MD.
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD, Fulton RW, Stegner JE, Goodyear MD, Witte SB, Taylor LP, Johnson BJ, Step DL, Ridpath JF, Holland BP.
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [Abstract] [Full Text] [Related]

  • 6. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA, Fairbanks KK, Behan S, Jackson JA, Goodyear M, Oien NL, Meinert TR, Leyh RD.
    Vet Ther; 2006 Mar; 7(3):295-304. PubMed ID: 17039452
    [Abstract] [Full Text] [Related]

  • 7. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD, Marley MS, Jones CA, Ensley DT, Galik PK, Zhang Y, Riddell KP, Joiner KS, Brodersen BW, Rodning SP.
    J Am Vet Med Assoc; 2012 Aug 15; 241(4):484-95. PubMed ID: 22852575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
    Palomares RA, Marley SM, Givens MD, Gallardo RA, Brock KV.
    Theriogenology; 2013 May 15; 79(8):1184-95. PubMed ID: 23561853
    [Abstract] [Full Text] [Related]

  • 10. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F, Magyar T, Rinehart C, Elbers K, Schlesinger K, Ohnesorge WC.
    Vet Microbiol; 2003 Oct 17; 96(2):117-31. PubMed ID: 14519330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W, Mattick D, Smith L.
    Vaccine; 2011 Jun 24; 29(29-30):4657-62. PubMed ID: 21596076
    [Abstract] [Full Text] [Related]

  • 14. Reproductive and economic impact following controlled introduction of cattle persistently infected with bovine viral diarrhea virus into a naive group of heifers.
    Rodning SP, Givens MD, Marley MS, Zhang Y, Riddell KP, Galik PK, Hathcock TL, Gard JA, Prevatt JW, Owsley WF.
    Theriogenology; 2012 Oct 15; 78(7):1508-16. PubMed ID: 22980084
    [Abstract] [Full Text] [Related]

  • 15. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
    Bolin SR, Lim A, Grotelueschen DM, McBeth WW, Cortese VS.
    Am J Vet Res; 2009 Jan 15; 70(1):86-91. PubMed ID: 19119952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH, Givens MD, Rodning SP, Riddell KP, Brodersen BW, Scruggs D, Short T, Grotelueschen D.
    Vaccine; 2017 Feb 15; 35(7):1046-1054. PubMed ID: 28111144
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
    Talens LT, Beckenhauer WH, Thurber ET, Cooley AJ, Schultz RD.
    J Am Vet Med Assoc; 1989 May 01; 194(9):1273-80. PubMed ID: 2542202
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK, Rinehart CL, Ohnesorge WC, Loughin MM, Chase CC.
    J Am Vet Med Assoc; 2004 Dec 15; 225(12):1898-904. PubMed ID: 15643841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.